ARDT vs PAYO
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ARDT · Ardent Health$17.30 ▲ 8.81%
PAYO · Payoneer Global$7.15 ▼ 0.28%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ARDT +26.6%
- PAYO +26.1%
Head to head
| Metric | ARDT | PAYO |
|---|---|---|
| Price | $17.30 | $7.15 |
| Change today | ▲ 8.81% | ▼ 0.28% |
| Market cap | $2.44B | $2.44B |
| Return, 3 months | +56.4% | +0.8% |
| Return, year to date | +95.9% | +27.2% |
| Return, 1 year | +20.1% | +33.1% |
| P/E (TTM) | 16.8 | 51.1 |
| P/B | 1.7 | 3.7 |
| P/E percentile vs own 5y | 72nd | 89th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -1.4% | +9.8% |
| Net profit growth (YoY) | -63.8% | -112.5% |
| Gross margin | 41.2% | – |
| Operating margin | 4.0% | -12.4% |
| Net margin | 1.2% | 5.8% |
| Return on equity | 6.0% | 7.1% |
| Analyst target vs. price | -29.0% | +3.5% |
| Analyst buy share | 56% | 0% |
| RSI (14) | 85 | 52 |
| 30-day volatility | 72.5% | 3.4% |
| Max drawdown, 1 year | -48.3% | -33.6% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ARDT is the largest of the group by market value.
- PAYO has returned the most over the past year.
- ARDT carries the lowest trailing P/E.
- PAYO is growing revenue fastest.
- PAYO keeps the most profit per dollar of sales.
- PAYO has been the calmest stock over the last 30 days.